2006
DOI: 10.1007/s11886-006-0023-0
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic modulation of myocardial ischemia

Abstract: The metabolic pathways of the heart during normoxia and ischemia have been well studied. High plasma fatty acid concentrations and the myocardial accumulation of long-chain fatty acyl metabolites during ischemia correlate with increased morbidity and mortality. However, enhanced glucose use can maintain cell homeostasis, diminish ischemic injury, and be clinically beneficial. Metabolic modulators represent a new class of drugs with the potential to treat myocardial ischemia. They are ideal as adjunctive anti-i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…It is entirely conceivable that fatty acids can serve as a more efficient fuel during IR 33 . On the other hand, metabolic modulators shifting metabolism preferentially to glucose utilization are a newer class of drugs to ameliorate IR injury 34 . Inhibition of fatty‐acid oxidation by etomoxir, for example, has been shown to be highly protective in hearts 35 .…”
Section: Discussionmentioning
confidence: 99%
“…It is entirely conceivable that fatty acids can serve as a more efficient fuel during IR 33 . On the other hand, metabolic modulators shifting metabolism preferentially to glucose utilization are a newer class of drugs to ameliorate IR injury 34 . Inhibition of fatty‐acid oxidation by etomoxir, for example, has been shown to be highly protective in hearts 35 .…”
Section: Discussionmentioning
confidence: 99%
“…The latter is in line with the present findings in Langendorff-prepared hearts from AGS where 1% Intralipid™ clearly improved post-IR function when given before and after IR. The role of glucose versus fatty acid metabolization in attenuating IR injury has indeed been the subject of a number of investigations and reviews (Jani and Bergmann 2006; Barsotti et al 2009; Jaswal et al 2011). On one side, it is entirely conceivable that fatty acids can serve as a more efficient fuel during myocardial IR (Jaswal et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…On one side, it is entirely conceivable that fatty acids can serve as a more efficient fuel during myocardial IR (Jaswal et al 2011). On the other hand, metabolic modulators shifting metabolism preferentially to glucose utilization are a newer class of drugs to ameliorate myocardial IR injury (Jani and Bergmann 2006). Inhibition of fatty acid oxidation by etomoxir, for example, has been shown to be highly cardioprotective (Lopaschuk et al 1988).…”
Section: Discussionmentioning
confidence: 99%
“…Although yielding more energy per mole of carbon, β oxidation of FAs consumes more oxygen per mole of ATP produced than does the catabolism of alternate substrates: Oxidation of 1 mol of the six-carbon FA, hexanoate, for example, generates 44 mol of ATP, whereas oxidation of the six-carbon carbohydrate, glucose, yields only 38 mol of ATP. However, oxidation of hexanoate requires 8 mol of oxygen, providing 5.5 mol of ATP for each mole of oxygen consumed, whereas only 6 mol of oxygen are needed for the complete oxidation of glucose, yielding 6.3 mol of ATP per mole of oxygen consumed [8].…”
Section: Myocardial Metabolism In Health and Diseasementioning
confidence: 99%